Biotech News - Myriad Genetics, Inc. (Public, NASDAQ:MYGN)

Myriad Genetics, Inc. (Public, NASDAQ:MYGN)

Myriad Genetics Announces First Quarter Fiscal 2007 Financial
Results Conference Call
SALT LAKE CITY Myriad Genetics, Inc. (NASDAQ:MYGN) has arranged a
conference call with the management team to provide a company
update. Peter Meldrum, President and Chief Executive Officer will
host the call along with Jay Moyes, Chief Financial Officer, Gregory
Critchfield, M.D., President of Myriad Genetic Laboratories, Inc.
and Adrian Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc.

DATE: November 7, 2006
TIME: 10:00 am ET
DOMESTIC DIAL-IN: (888) 589-2820
INTERNATIONAL DIAL-IN: (706) 634-2173
CONFERENCE ID# 9681049
(Please dial in approximately 10 minutes before the call is
scheduled to begin)

A press release will be issued at 6:30 am ET on November 7, 2006.
Replay of the call will be available from two hours after the call
through November 14th by dialing (800) 642-1687 or (706) 645-9291,
and entering conference ID number 9681049.

A live audio Webcast will be available at: www.myriad.com

http://tech.groups.yahoo.com/group/biotech-news/
http://www.arizonabiotech.com/
http://www.azhttp.com/

http://www.arizonabiotech.com/
http://groups.yahoo.com/group/biotech-news/
http://www.arizonaentrepreneurs.com/
http://www.azhttp.com/

Yahoo! Groups Links

<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/biotech-news/

<*> Your email settings:
Individual Email | Traditional

<*> To change settings online go to:
http://groups.yahoo.com/group/biotech-news/join
(Yahoo! ID required)

<*> To change settings via email:
mailto:biotech-news-digest@yahoogroups.com
mailto:biotech-news-fullfeatured@yahoogroups.com

<*> To unsubscribe from this group, send an email to:
biotech-news-unsubscribe@yahoogroups.com

<*> Your use of Yahoo! Groups is subject to:
http://docs.yahoo.com/info/terms/